Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114959) titled 'Immune homeostasis regulatory therapy in elderly sepsis patients: A multicenter, randomized, double-blind Pilot study' on Dec. 19, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital, Sun Yat-sen University
Condition:
Sepsis
Intervention:
experimental group:1ml subcutaneous injection with 1.6 mg thymosin every 12±2 hours and 20ml intravenous injection with 200,000 units ulinastatin every 8±1 hours
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2025-12-22
Target Sample Size: experimental group:30;Control group:3...